Hankey BF, Feuer EJ, Clegg LX.
et al. Cancer Surveillance Series: interpreting trends in prostate cancer,
part I: evidence of the effects of screening in recent prostate cancer incidence,
mortality, and survival rates. J Natl Cancer Inst.1999;91:1017-1024.
Brawer M. Prostate-specific antigen: current status. CA Cancer J Clin.1999;49:264-281.
Catalona WJ, Ramos CG, Carvalhal GF, Yan Y. Lowering PSA cutoffs to enhance detection of curable prostate cancer. Urology.2000;55:791-795.
Donovan JL, Frankel SJ, Neal DE, Hamdy FC. Screening for prostate cancer in the UK: seems to be creeping in by
the back door. BMJ.2001;323:763-764.
Hahn DL. Lack of knowledge regarding prostate-specific antigen screening: is
ignorance bliss? J Fam Pract.1999;48:679-681.
Labrie F. Screening and early treatment of prostate cancer are accumulating strong
evidence and support. Prostate.2000;43:215-222.
Mettlin C. Public health impact of prostate cancer early detection. Prostate.1997;31:71-73.
Barry MJ. Early detection and aggressive treatment of prostate cancer: groping
in the dark. J Gen Intern Med.2000;15:749-751.
Labrie F, Candas B, Dupont A.
et al. Screening decreases prostate cancer death: first analysis of the 1988
Quebec prospective randomized controlled trial. Prostate.1999;38:83-91.
Boer R, Schroder FH. Quebec randomized controlled trial on prostate cancer screening shows
no evidence for mortality reduction [letter]. Prostate.1999;40:130-131.
Labrie F, Candas B. Various statistical analyses indicate a marked reduction of prostate
cancer death in the Quebec trial. Prostate.1999;40:132-134.
Alexander FE, Prescott RJ. Reply to Labrie et al: results of the mortality analysis of the Quebec
randomized/controlled trial (RCT). Prostate.1999;40:135-137.
Labrie F, Candas B. The Quebec study shows a 69% decrease in prostate cancer death [letter]. Prostate.1999;40:137.
American College of Physicians. Screening for prostate cancer. Ann Intern Med.1997;126:480-484.
US Preventive Services Task Force. Screening for prostate cancer. In: Guide to Clinical Preventive Services. 2nd
ed. Baltimore, Md: Williams & Wilkins; 1996:119-134.
Smith RA, Cokkinides V, von Eschenbach AC.
et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin.2002;52:8-22.
Carroll P, Coley C, McLeod D.
et al. Prostate-specific antigen best practice policy, part I: early detection
and diagnosis of prostate cancer. Urology.2001;57:217-224.
Ransohoff DF, Sandler RS. Clinical practice: screening for colorectal cancer. N Engl J Med.2002;346:40-44.
Eddy DM. Screening for colorectal cancer. Ann Intern Med.1990;113:373-384.
US Preventive Services Task Force. Screening for colorectal cancer. In: Guide to Clinical Preventive Services. 2nd
ed. Baltimore, Md: Williams & Wilkins; 1996:89-103.
Winawer SJ, Fletcher RH, Miller L.
et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology.1997;112:594-642.
Rex DK, Johnson DA, Lieberman DA.
et al. Colorectal cancer prevention 2000: screening recommendations of the
American College of Gastroenterology. Am J Gastroenterol.2000;95:868-877.
Mandel JS, Bond JH, Church TR.
et al. Reducing mortality from colorectal cancer by screening for fecal occult
blood. N Engl J Med.1993;328:1365-1371.
Kronborg O, Fenger C, Olsen J.
et al. Randomised study of screening for colorectal cancer with faecal-occult-blood
Hardcastle JD, Chamberlain JO, Robinson MHE.
et al. Randomised controlled trial of faecal-occult-blood screening for colorectal
Fowler FJ, Bin L, Collins MM.
et al. Prostate cancer screening and beliefs about treatment efficacy: a national
survey of primary care physicians and urologists. Am J Med.1998;104:526-532.
Selby JV, Friedman GD, Quesenberry Jr CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from
colorectal cancer. N Engl J Med.1992;326:653-657.
Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy:
a case-control study of 32,702 veterans. Ann Intern Med.1995;123:904-910.
Not Available. Trends in screening for colorectal cancer—United States, 1997
and 1999. MMWR Morb Mortal Wkly Rep.2001;50:162-166.
Hoffman RM, Papenfuss MR, Buller DB, Moon TE. Attitudes and practices of primary care physicians for prostate cancer
screening. Am J Prev Med.1996;12:277-281.
Voss JD, Schectman JM. Prostate cancer screening practices and beliefs: a longitudinal physician
survey. J Gen Intern Med.2001;16:831-837.
Centers for Disease Control and Prevention. 2001 Behavioral Risk Factor Surveillance System Summary
Data Quality Report. Atlanta, Ga: US Dept of Health and Human Services; 2002.
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK. SEER Cancer Statistics Review, 1973-1999. Bethesda, Md: National Cancer Institute; 2002. Available at: http://seer.cancer.gov/csr/1973_1999/. Accessed May 25, 2002.
Not Available. Surveillance, Epidemiology, and End Results. SEER Incidence and US Mortality Statistics.Bethesda, Md: National Cancer Institute; 1999. Available at: http://seer.cancer.gov/canques/. Accessed September 18, 2002.
Population Estimates Program, Population Division. Annual Population Estimates by Age Group and Sex,
Selected Years from 1990 to 2000. Washington, DC: US Census Bureau; 2001. Available at: http://eire.census.gov/popest/data/age.php. Accessed September 18, 2002.
Standaert B, Denis L. The European Randomized Study of Screening for Prostate Cancer: an
Prorok PC, Andriole GL, Bresalier RS.
et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer
Screening Trial. Control Clin Trials.2000;21:273S-309S.
Farrell MH, Murphy MA, Schneider CE. How underlying patient beliefs can affect physician-patient communication
about prostate-specific antigen. Eff Clin Pract.2002;5:91-94.
Woloshin S, Schwartz LM. The US Postal Service and cancer screening: stamps of approval? N Engl J Med.1999;340:884-887.
Hawley ST, Levin B, Vernon SW. Colorectal screening by primary care physicians in two medical care
organizations. Cancer Detect Prev.2001;25:309-318.
Schroy 3rd PC, Geller AC, Crosier Wood M.
et al. Utilization of colorectal cancer screening tests: a 1997 survey of
Massachusetts internists. Prev Med.2001;33:381-391.
Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening: a randomized
controlled trial. Ann Intern Med.2000;133:761-769.
National Center for Health Statistics. National Health Interview Survey Data. Hyattsville, Md: Division of Health Interview Statistics, National
Center for Health Statistics; 2000.
McGovern PG, Lurie N, Margolis KL, Slater JS. Accuracy of self-report of mammography and Pap smear in a low-income
urban population. Am J Prev Med.1998;14:201-208.
Suarez L, Goldman DA, Weiss NS. Validity of Pap smear and mammogram self-reports in a low-income Hispanic
population. Am J Prev Med.1995;11:94-98.
Whitman S, Lacey L, Ansell D.
et al. Do chart reviews and interviews provide the same information about
breast and cervical cancer screening? Int J Epidemiol.1993;22:393-397.
Bowman JA, Redman S, Dickinson JA.
et al. The accuracy of Pap smear utilization self-report: a methodological
consideration in cervical screening research. Health Serv Res.1991;26:97-107.
Volk RJ, Cass AR. The accuracy of primary care patients' self-reports of prostate-specific
antigen testing. Am J Prev Med.2002;22:56-58.
Jordan TR, Price JH, King KA.
et al. The validity of male patients' self-reports regarding prostate cancer
screening. Prev Med.1999;28:297-303.
Mandelson MT, LaCroix AZ, Anderson LA.
et al. Comparison of self-reported fecal occult blood testing with automated
laboratory records among older women in a health maintenance organization. Am J Epidemiol.1999;150:617-621.
Baier M, Calonge N, Cutter G.
et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev.2000;9:229-232.
Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst.1997;89:1406-1422.